Document Detail

Retrospective analysis of prognosticators in patients with relapsed Hodgkin's Lymphoma treated with autologous transplant: results of a single center.
MedLine Citation:
PMID:  23292874     Owner:  NLM     Status:  In-Data-Review    
Hodgkin's Lymphoma (HL) is highly chemoresponsive, and majority of patients respond to therapy except for a small number which require high-dose therapy and stem cell rescue for salvage. We report the results of a single-center experience in 41 patients with relapsed HL treated with high-dose therapy at the time of relapse from the year 1989-2010. The 7-year OS for the group is 39.2 %; the median progression-free survival is 30.6 months. Univariate analysis identified refractory disease at transplant and extranodal involvement as important prognosticators. The 100-day mortality was 5 %. The most common cause for delayed mortality was disease progression. The incidence of secondary malignancy in the group was 2 %. Our results reinforce the significance of long-term follow up as late relapses are observed. Additionally, identifying biological prognosticators and implying them for treatment may improve the outcomes in poor-risk patients.
Aisha Masood; Amir Steinberg; Erin Moshier; Adriana Malone; Eileen Scigliano; Jacqueline Nieto; Keren Osman; Celia Grosskreutz; Luis Isola; Joshua Brody
Related Documents :
16416114 - Addition of cyclosporin-a to chemotherapy in secondary (post-mds) aml in the elderly. a...
25006504 - Vinorelbine with or without trastuzumab in metastatic breast cancer: a retrospective si...
25157404 - Proliferation index: a continuous model to predict prognosis in patients with tumours o...
23462324 - Gemcitabine plus capecitabine in unselected patients with advanced pancreatic cancer.
25168544 - Adult prostate sarcoma: the memorial sloan kettering experience.
1642414 - Metastatic melanoma with an unknown primary.
Publication Detail:
Type:  Journal Article     Date:  2013-01-06
Journal Detail:
Title:  Medical oncology (Northwood, London, England)     Volume:  30     ISSN:  1559-131X     ISO Abbreviation:  Med. Oncol.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-01-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435512     Medline TA:  Med Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  431     Citation Subset:  IM    
Department of Bone Marrow Transplant, The Tisch Cancer Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular ca...
Next Document:  Anodic-Stripping Voltammetric Immunoassay for Ultrasensitive Detection of Low-Abundance Proteins Usi...